President’s Biden’s nomination of Robert Califf to head the Food and Drug Administration is in the political crosshairs. Curiously, the attacks are not from the usual suspects. Instead, they are friendly fire discharged by an unlikely trio of Democrats: Sens. Bernie Sanders, Elizabeth Warren, and Joe Manchin, who are concerned about Califf’s past involvement with the pharmaceutical industry.
These concerns are unwarranted and show a disturbing lack of understanding and superficial knowledge of the experience needed in drug development and clinical research to lead the nation’s leading regulatory agency for therapeutics.